# Role of Gut Microbiome in Cancer Therapy

> **NCT05112614** · — · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 3000 (estimated)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Electronic Health Record Review

## Key facts

- **NCT ID:** NCT05112614
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-11
- **Primary completion:** 2030-10-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05112614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05112614, "Role of Gut Microbiome in Cancer Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05112614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*